ArticleSurgery open science2026
Development and frontier trends of research on the gut microbiota and cholangiocarcinoma.
Article in Surgery open science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although research on the gut microbiota and cholangiocarcinoma has developed rapidly in recent years, and the gut microbiota plays an important role in cholangiocarcinoma, there is currently a lack of comprehensive and objective understanding of the latest progress and future research directions in this field. This study comprehensively evaluated and visually analyzed this research area based on bibliometric methods. Methods: This analysis used tools such as the "Bibliometrix" R package, VOSviewer, CiteSpace, and Microsoft Office Excel (2019 version) to comprehensively conduct a bibliometric analysis of scientific research outputs related to the gut microbiota and cholangiocarcinoma. The data analyzed were all sourced from the Web of Science Core Collection (2009-2025). Results: A total of 124 research achievements published from 2009 to 2025 were included. Eight hundred and ninety-six researchers from 278 institutions in 37 countries/regions participated in the research on the gut microbiota and cholangiocarcinoma. The number of global publications has steadily increased, reaching a peak in 2024. China had the most publications and citations, followed by Italy and the United States. The University of Oslo, Khon Kaen University, and Università degli Studi di Palermo were the main institutions in this research area and made important contributions. Conclusion: This study comprehensively summarized the development of research on the gut microbiota and cholangiocarcinoma from 2009 to 2025. The research results revealed the latest research frontiers and hotspots in this field and provided valuable insights for future research. However, it should be noted that although WoSCC is a widely recognized and authoritative database, it may have limitations in terms of regional bias, language coverage, and metadata accuracy, which may affect the comprehensiveness of our analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.